FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug
Confidence boost for AI virtual cells for novel target discovery
Anti-fibrotic drug could be repurposed to control cell communication
Positive data from oral therapy designed to improve muscle function and body composition
Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
Antibody targeting TSLP achieves positive results in asthma study
Clinical trial shows knee osteoarthritis pain improvement
Preclinical paper on CD73 small molecule inhibitor
Positive results from relapsed/refractory B-cell lymphoma trial